Patent details
EP3038652 Title: COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
Basic Information
- Publication number:
- EP3038652
- PCT Application Number:
- US2014053244
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP147663017
- PCT Publication Number:
- WO2015031666
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
- French Title of Invention:
- COMBINAISON D'UN INHIBITEUR D'ALK ET D'UN INHIBITEUR DE CDK POUR LE TRAITEMENT DE MALADIES PROLIFÉRATIVES CELLULAIRES
- German Title of Invention:
- KOMBINATION VON ALK- UND CDK-HEMMERN ZUR BEHANDLUNG ZELLPROLIFERATIVER ERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 28/08/2014
- Grant date:
- 21/03/2018
- EP Publication Date:
- 06/07/2016
- PCT Publication Date:
- 05/03/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/03/2018
- EP B1 Publication Date:
- 21/03/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/08/2018
- Expiration date:
- 28/08/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/03/2018
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- HARRIS, Jennifer Leslie
- Address:
- United States (US)
2
- Name:
- LI, Nanxin
- Address:
- United States (US)
3
- Name:
- SMITH, Timothy R.
- Address:
- United States (US)
Priority
- Priority Number:
- 201361871275 P
- Priority Date:
- 28/08/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/506; A61K 31/519; A61K 45/06; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 201812
- Publication date:
- 21/03/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 31/12/2018 | Outgoing Correspondence | 1 |